Newbury Street II Acquisition Corp
NASDAQ:NTWOShell Companies
+$0.01 today
- Market cap
- $195.82M
- Beta
- 0.04
- P/E (TTM)
- 29.0
- EPS (TTM)
- $0.37
Volume 0.01M
Average 0.00M
NTWO Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Newbury Street II Acquisition CorpNASDAQ: NTWO
Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026
Cash & equivalents falls 55.9% from a year ago
Cash & equivalents stood at $497.39K at the end of Q1 FY2026, down 55.9% from a year earlier and down 35.6% from the prior quarter.
Context
- Cash & equivalents amounted to 0.3% of total assets at the end of Q1 FY2026, down 0.4 pp from a year earlier.
What to watch
Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -55.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 772.51K USD
- Year-over-year change
- -37.6%
- 1-year CAGR
- -37.6%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 772.51K | -37.6% |
| FY2024 | 2024-12-31 | 1.24M | — |
Cash & Equivalents vs competitors
How NTWO compares with its peers on the latest reported figures
- NTWO's Mar 2026 cash & equivalents of $497.39K is the 2nd highest of the 8 companies compared; the peer median is $25K.
- Its year-over-year change of -55.9% is the 2nd highest of 6, against a peer median of -90.9%.
- Cash & equivalents amounts to 0.3% of total assets for NTWO, versus a peer median of 0.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $653.38K | — | -0.8% | 0.3% | |
NTWONewbury Street II Acquisition Corp | Mar 2026 | $497.39K | -55.9% | — | 0.3% |
IPODDune Acquisition Corporation II | Mar 2026 | $84.21K | +17816.4% | — | 0.1% |
RFAIRF Acquisition Corp II Ordinary Shares | Mar 2026 | $34.74K | -95.7% | — | 0.1% |
| Mar 2026 | $25K | -90.9% | — | 0.0% | |
| Mar 2026 | $24.63K | -88.1% | +137.4% | 0.0% | |
IBACIB Acquisition Corp. Common Stock | Mar 2026 | $4.63K | -99.3% | +437.5% | 0.1% |
| Jun 2025 | $0 | — | — | 0.0% | |
| Peer median (excluding NTWO) | $25K | -90.9% | +137.4% | 0.1% | |
Competitors are the stored peer set for NTWO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|
| Cash & Equivalents | 1.24M | 772.51K |
| Short-term Investments | 0 | 0 |
| Net Receivables | 25K | 32.59K |
| Inventory | 0 | 0 |
| Other Current Assets | 0 | 0 |
| Total Current Assets | 1.45M | 896.27K |
| Property, Plant & Equipment (Net) | 0 | 0 |
| Goodwill | 0 | 0 |
| Intangible Assets | 0 | 0 |
| Long-term Investments | 174.58M | 181.85M |
| Tax Assets | 0 | 0 |
| Other Non-current Assets | 86.67K | 0 |
| Total Non-current Assets | 174.67M | 181.85M |
| Total Assets | 176.11M | 182.74M |
| Account Payables | 38.68K | 0 |
| Short-term Debt | 0 | 0 |
| Tax Payables | 0 | 0 |
| Deferred Revenue | 0 | 0 |
| Other Current Liabilities | 0 | 147.3K |
| Total Current Liabilities | 138.94K | 147.3K |
| Long-term Debt | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 |
| Deferred Revenue (Non-current) | 6.04M | 6.04M |
| Other Non-current Liabilities | 0 | 0 |
| Total Non-current Liabilities | 6.04M | 6.04M |
| Total Liabilities | 6.18M | 6.18M |
| Common Stock | 174.58M | 181.85M |
| Retained Earnings | (4.64M) | (5.29M) |
| Accumulated OCI | 0 | 0 |
| Other Stockholders Equity | 0 | 0 |
| Minority Interest | 0 | 0 |
| Total Equity | 169.94M | 176.56M |
| Total Debt | 0 | 0 |
| Net Debt | (1.24M) | (772.51K) |
Newbury Street II Acquisition Corp
NASDAQ:NTWO
Intrinsic Alpha fair value
Locked
Current Price
$10.88
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.